Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men
Titel:
Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men
Auteur:
Giuliano, Anna R. Wilkin, Timothy Bautista, Oliver M. Cheon, Kyeongmi Connor, Laurie Dubey, Sheri Luxembourg, Alain Rawat, Sonali Shaw, Anita Velicer, Christine Vendetti, Neika Tu, Yingmei
Verschenen in:
Contemporary clinical trials
Paginering:
Jaargang 115 () nr. C pagina's p.
Jaar:
2022
Inhoud:
Uitgever:
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, The Author(s)